| Pharmaceutical Information |
| Drug Name |
Prednisolone |
| Drug ID |
BADD_D01831 |
| Description |
Prednisolone is a glucocorticoid similar to [cortisol] used for its anti-inflammatory, immunosuppressive, anti-neoplastic, and vasoconstrictive effects.[A187463]
Prednisolone was granted FDA approval on 21 June 1955.[L9431] |
| Indications and Usage |
Prednisolone is indicated to treat endocrine, rheumatic, and hematologic disorders; collagen, dermatologic, ophthalmic, respiratory, and gastrointestinal diseases; allergic and edematous states; and other conditions like tuberculous meningitis.[L9542] |
| Marketing Status |
approved; vet_approved |
| ATC Code |
A01AC04; A07EA01; C05AA04; D07AA03; D07XA02; H02AB06; R01AD02; S01BA04; S01CB02; S02BA03; S03BA02 |
| DrugBank ID |
DB00860
|
| KEGG ID |
D00472
|
| MeSH ID |
D011239
|
| PubChem ID |
5755
|
| TTD Drug ID |
D0D1SG
|
| NDC Product Code |
38779-0150; 64958-0097; 82298-104; 67296-1656; 50383-042; 59651-491; 63187-466; 0527-5406; 65089-0038; 50090-0655; 57582-004; 62135-437; 73534-505; 49452-5980; 82298-105; 82298-106; 60592-911; 60722-3001; 51927-0234; 22552-0052 |
| UNII |
9PHQ9Y1OLM
|
| Synonyms |
Prednisolone | Predate | Predonine | Di-Adreson-F | Di Adreson F | DiAdresonF |
|
| Chemical Information |
| Molecular Formula |
C21H28O5 |
| CAS Registry Number |
50-24-8 |
| SMILES |
CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
| ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
| Trichoglossia | 07.14.01.021 | 0.000052% | | - |
|
|
|
